PURPOSE: Bone marrow failure (BMF) in idiopathic aplastic anemia (AA) and hypoplastic myelodysplastic neoplasms (MDS-h) results from the destruction of hematopoietic progenitors by autoreactive T cells; however, the molecular events driving the pathogenesis of these disorders remain unclear. We therefore applied whole-exome sequencing (WES) in AA and MDS-h patients to identify acquired and inherited gene variants presumed to have functional consequences for BMF. We also used transcriptome profiling to investigate the molecular mechanisms underlying the aberrant T cell response. METHODS: WES was performed on DNA from 42 patients at diagnosis. Transcriptome profiling of CD3⁺ cells was conducted in 21 patients and 10 healthy donors. Peripheral blood cell populations were analyzed by flow cytometry. RESULTS: Pathogenic/likely pathogenic (P/LP) somatic gene variants were detected in 79% of patients and were functionally associated with BMF-relevant processes such as antigen processing/presentation, T cell-mediated immunity, and DNA repair. P/LP germline gene variants were found in all patients, almost half of whom harbored variants associated with inborn errors of immunity. Patient T cells displayed expression signatures of increased inflammation, apoptosis, hypoxia response, and decreased oxidative phosphorylation. Dysregulated long noncoding RNAs were predicted to primarily regulate the differentiation of T helper 17 cells. Patients also showed significantly lower frequencies of immature progenitors and natural killer cells compared with controls. CONCLUSION: Patients with idiopathic AA and MDS-h carried multiple germline immune-related gene variants that may increase susceptibility to immune-mediated BMF. Furthermore, patient T cells exhibited altered energy metabolism, which may represent a therapeutic target for modulating immune responses in autoimmune diseases.

1st Department of Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

1st Faculty of Medicine Charles University Prague Czech Republic

Department of Hematology and Oncology University Hospital Pilsen Pilsen Czech Republic

Faculty of Science Charles University Prague Czech Republic

Institute of Clinical and Experimental Hematology 1st Faculty of Medicine Charles University Prague Czech Republic

Institute of Hematology and Blood Transfusion Prague Czech Republic

Zobrazit více v PubMed

Votavova H, Belickova M. Hypoplastic myelodysplastic syndrome and acquired aplastic anemia: Immune-mediated bone marrow failure syndromes (Review). Int J Oncol. 2022;60(1):7. PubMed PMC

Li JP, Zheng CL, Han ZC. Abnormal immunity and stem/progenitor cells in acquired aplastic anemia. Crit Rev Oncol Hematol. 2010;75(2):79–93. PubMed

Schoettler ML, Nathan DG. The pathophysiology of acquired aplastic anemia current concepts revisited. Hematol Oncol Clin North Am. 2018;32(4):581. PubMed PMC

Olson TS, Frost BF, Duke JL, Dribus M, Xie HBM, Prudowsky ZD et al. Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities. JCI Insight. 2022;7(22):e163040. PubMed PMC

Kulasekararaj AG, Jiang J, Smith AE, Mohamedali AM, Mian S, Gandhi S, et al. Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome. Blood. 2014;124(17):2698–704. PubMed PMC

Yao CY, Hou HA, Lin TY, Lin CC, Chou WC, Tseng MH, et al. Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS). Oncotarget. 2016;7(39):63177–88. PubMed PMC

Yoshizato T, Dumitriu B, Hosokawa K, Makishima H, Yoshida K, Townsley D, et al. Somatic mutations and clonal hematopoiesis in aplastic anemia. N Engl J Med. 2015;373(1):35–47. PubMed PMC

Chen FF, Hu SM, Ruan J, Chen M, Han B. Mutational landscape and its clinical significance in paroxysmal nocturnal hemoglobinuria. Blood Cancer J. 2021;11(3):58. 10.1038/s41408-021-00451-1 PubMed PMC

Kulasekararaj A, Cavenagh J, Dokal I, Foukaneli T, Gandhi S, Garg M, et al. Guidelines for the diagnosis and management of adult aplastic anaemia: a British society for haematology guideline. Br J Haematol. 2024;204(3):784–804. PubMed

Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36(7):1703–19. PubMed PMC

Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120(12):2454–65. PubMed PMC

Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Aguilera MA, Meyer R, et al. Varsome: the human genomic variant search engine. Bioinformatics. 2019;35(11):1978–80. PubMed PMC

Kaisrlikova M, Vesela J, Kundrat D, Votavova H, Merkerova MD, Krejcik Z, et al. PubMed PMC

Ma WB, Liu YN, Ma HS, Ren ZR, Yan JB. Cis-acting: a pattern of LncRNAs for gene regulation in induced pluripotent stem cells from patients with down syndrome determined by integrative analysis of LncRNA and mRNA profiling data. Exp Ther Med. 2021;22(1):701. 10.3892/etm.2021.10133 PubMed PMC

Peng B, Li HW, Na RS, Lu T, Li YC, Zhao JY, et al. Identification of a novel prognostic signature of genome instability-related lncRNAs in early stage lung adenocarcinoma. Front Cell Dev Biol. 2021;9:706454. 10.3389/fcell.2021.706454 PubMed PMC

Augustino SMA, Xu QL, Liu XQ, Mi SY, Shi LY, Liu YB, et al. Integrated analysis of LncRNAs and mRNAs reveals key PubMed PMC

Xiang JF, Yin QF, Chen T, Zhang Y, Zhang XO, Wu Z, et al. Human colorectal cancer-specific PubMed PMC

Bono E, McLornan D, Travaglino E, Gandhi S, Galli A, Khan AA, et al. Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome. Leukemia. 2019;33(10):2495–505. PubMed

Deng XZ, Du M, Peng J, Long JX, Zheng CJ, Tan Y, et al. Associations between the HLA-A/B/DRB1/ polymorphisms and aplastic anemia: evidence from 17 case-control studies. HEMATOLOGY. 2018;23(3):154–62. PubMed

Osumi T, Miharu M, Saji H, Kusunoki Y, Kojima H, Nakamura J, et al. Nonsense mutation in PubMed

Pagliuca S, Gurnari C, Hercus C, Hergalant S, Nadarajah N, Wahida A, et al. Molecular landscape of immune pressure and escape in aplastic anemia. Leukemia. 2023;37(1):202–11. PubMed PMC

Moog-Lutz C, Peterson EJ, Lutz PG, Eliason S, Cavé-Riant F, Singer A, et al. PRAM-1 is a novel adaptor protein regulated by retinoic acid (RA) and promyelocytic leukemia (PML)-RA receptor α in acute promyelocytic leukemia cells. J Biol Chem. 2001;276(25):22375–81. PubMed

Sinthuwiwat T, Buranapraditkun S, Kamolvisit W, Tongkobpetch S, Chetruengchai W, Srichomthong C, et al. A LILRB1 variant with a decreased ability to phosphorylate SHP-1 leads to autoimmune diseases. Sci Rep. 2022;12(1):15420. 10.1038/s41598-022-19334-x PubMed PMC

Lundtoft C, Sjöwall C, Rantapää-Dahlqvist S, Bengtsson AA, Jönsen A, Pucholt P, et al. Strong association of combined genetic deficiencies in the classical complement pathway with risk of systemic lupus erythematosus and primary sjogren’s syndrome. Arthritis Rheumatol. 2022;74(11):1842–50. PubMed PMC

Bravo-Perez C, Gurnari C, Guarnera L, Kawashima N, Unlu S, Mandala A et al. Bone Marrow Failure and Inborn Errors of Immunity: An Immunogenomic Crossroad. Blood. 2023;142(65th Annual Meeting of the American-Society-of-Hematology (ASH)).

Zhu CY, Lian Y, Wang CC, Wu P, Li X, Gao Y, et al. Single-cell transcriptomics dissects hematopoietic cell destruction and T-cell engagement in aplastic anemia. Blood. 2021;138(1):23–33. PubMed PMC

Shen YY, Liu Q, Li HC, Liu WB, Hu HJ, Zhao YC, et al. Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study. Ann Hematol. 2023;102(3):503–17. PubMed PMC

McReynolds LJ, Rafati M, Wang YJ, Ballew BJ, Kim J, Williams VV, et al. Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes. Blood. 2022;140(8):909–21. PubMed PMC

Wang PC, Jiang WZ, Lai TY, Liu Q, Shen YY, Ye BD, et al. Germline variants in acquired aplastic anemia: current knowledge and future perspectives. Haematologica. 2024;109(9):2778–89. PubMed PMC

Kubota Y, Zawit M, Durrani J, Shen WY, Bahaj W, Kewan T, et al. Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasia. Leukemia. 2022;36(12):2827–34. PubMed

Feurstein S, Churpek JE, Walsh T, Keel S, Hakkarainen M, Schroeder T, et al. Germline variants drive myelodysplastic syndrome in young adults. Leukemia. 2021;35(8):2439–44. PubMed PMC

Nie DJ, Zhang J, Wang F, Li X, Liu LL, Zhang W, et al. Fanconi anemia gene-associated germline predisposition in aplastic anemia and hematologic malignancies. Front Med. 2022;16(3):459–66. PubMed

Calado RT, Graf SA, Wilkerson KL, Kajigaya S, Ancliff PJ, Dror Y, et al. Mutations in the PubMed PMC

Kempkes RWM, Joosten I, Koenen H, He XH. Metabolic pathways involved in regulatory T cell functionality. Front Immunol. 2019;10:2839. 10.3389/fimmu.2019.02839 PubMed PMC

Shi LZ, Wang RN, Huang GH, Vogel P, Neale G, Green DR, et al. HIF1α-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of T PubMed PMC

Tang CL, Chen S, Qian H, Huang WL. Interleukin-23: as a drug target for autoimmune inflammatory diseases. Immunology. 2012;135(2):112–24. PubMed PMC

Shui XL, Chen SM, Lin JT, Kong JZ, Zhou CW, Wu JZ. Knockdown of LncRNA NEAT1 inhibits Th17/CD4 < SUP>+ T cell differentiation through reducing the STAT3 protein level. J Cell Physiol. 2019;234(12):22477–84. PubMed

Hu XJ, Gu Y, Wang YX, Cong YQ, Qu X, Xu CG. Increased CD4 + and CD8 + effector memory T cells in patients with aplastic anemia. HAEMATOLOGICA-THE Hematol J. 2009;94(3):428–9. PubMed PMC

Giudice V, Feng XM, Lin ZH, Hu W, Zhang FM, Qiao WM, et al. Deep sequencing and flow cytometric characterization of expanded effector memory CD8 + CD57 + T cells frequently reveals T-cell receptor Vβ oligoclonality and CDR3 homology in acquired aplastic anemia. Haematologica. 2018;103(5):759–69. PubMed PMC

Wang JW, Zhou RQ, Zhong LM, Chen YC, Wu XJ, Huang LP, et al. High-dimensional immune profiling using mass cytometry reveals IL-17A-producing γδ T cells as biomarkers in patients with T-cell-activated idiopathic severe aplastic anemia. Int Immunopharmacol. 2023;125(Pt B):111163. 10.1016/j.intimp.2023.111163 PubMed

Liu CY, Li ZS, Sheng WW, Fu R, Li LJ, Zhang T, et al. Abnormalities of quantities and functions of natural killer cells in severe aplastic anemia. Immunol Invest. 2014;43(5):491–503. PubMed